Pneumotoxicity of dust from aluminum foundry and pure alumina: A comparative study of morphology and biomarkers in rats

International Journal of Occupational Medicine and Environmental Health

Volumn 18, Issue 1, 2005, Pages 59-70

  Hałatek, Tadeusz ^a   Opalska, Barbara ^a   Lao, Iwona ^a   Stetkiewicz, Jan ^a   Rydzyński, Konrad ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Aluminum; Clara cell protein; Foundry dust; Metaloproteinases; Morphology

Indexed keywords

ALUMINUM; ALUMINUM OXIDE; BIOLOGICAL MARKER; CLARA CELL PROTEIN; COLLAGEN; ELASTASE INHIBITOR; GELATINASE A; GELATINASE B; GLUTATHIONE TRANSFERASE; HYALURONIC ACID; METALLOPROTEINASE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLARA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DUST; EPITHELIUM CELL; FEMALE; FUME; INTRATRACHEAL DRUG ADMINISTRATION; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; LUNG LAVAGE; LUNG TOXICITY; NONHUMAN; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PATHOGENESIS; POLYMORPHONUCLEAR CELL; RAT; RESPIRATORY TRACT INFLAMMATION; SEDIMENT; SENSITIVITY AND SPECIFICITY;

EID: 18344388113     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Abramson MJ, Włodarczyk JH, Saunders NA, Hensley MJ. Does aluminium smelting cause lung disease? State of the art. Am Rev Respir Dis 1989;139:1042-57.
2. Kongerud J, Boe J, Soyseth V, Naalsund A, Mangus P. Aluminium potroom asthma: the Norwegian experience. Reviev Eur Respir J 1994;7:165-72.
3. Vandenplas O, Delwiche JP, Vanbilse ML, Joly J, Roosels D. Occupational asthma caused by aluminium welding. Eur Resp J 1998;11:1182-4.
4. Barnard CG, McBride DI, Firth HM, Herbison GP. Assessing individual employee risk factors for occupational asthma in primary aluminium smelting. Occup Environ Med 2004;61:604-8.
5. Bergamaschi E, Apostoli P, Catalani S, Festa D, Folesani G, Andreoli R, et al. Indicators of pulmonary epithelial damage among workers at a foundry exposed to airborne pollutants. G Ital Med Lav Ergon 2003;25:104-6.
6. Finkelstein JN, Johnston C, Gerdin B, Hallgren R. Dynamic role of hyalurona (HYA) in connective tissue activation and inflammation. J Intern Med 1997;242:49-55.
7. Plopper CG, Chang AM, Pang A, Buckpitt AR. Use of microdissected airways to define metabolism and cytotoxicity in murine bronchiolar epithelium. Exp Lung Res 1991;17:197-212.
8. West JA, Pakehham G, Morin D, Fleschner CA, Buckpitt AR, Plopper CG. Inhaled naphthalene causes dose dependent Clara cell cytotoxicity in mice but not in rats. Toxicol Appl Pharmacol 2001;173:114-9.
9. Baldwin RM, Shultz MA, Buckpitt AR. Bioactivation of the pulmonary toxicants. naphthalene and 1-nitronaphthalene by rat CYP2F4. J Pharmacol Exp Ther 2005;312:857-65.
10. Barth PJ, Koch S, Muller B, Unterstab F, von Wichert P, Moll R. Proliferation and number of Clara cell 10-kDa protein (CC10)-reactive epithelial cells and basal cells in normal, hyperplastic and metaplastic bronchial mucosa. Virchows Arch 2000;437:648-55.
11. Otto WR. Lung epithelial stem cells. J Pathol 2002;197:527-35.
12. Mantile G, Miele L, Cordella-Miele E, Singh G, Katyal SL, Mukherjee AB. Human Clara cell 10-kDa protein is the counterpart of rabbit uteroglobin. J Biol Chem 1993;268:65-75.
13. Lesur O, Bernard A, Arsalane K, Lauwerys R, Begin R, Cantin A, et al. Clara cell protein (CC16) induces a Phospholipase A2-mediated inhibition of fibroblasts migration in vitro. Am J Respir Crit Care Med 1995;152:290-7.
14. Singh G, Katyal SL. Clara cells and Clara cell 10 kD protein (CC10). Am J Respir Cell Mol Biol 1997;17:141-3.
15. Halatek T, Hermans C, Broeckaert F, Wattiez R, Wiedig M, Toubeau G, et al. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Resp J 1998;11:726-33.
16. Hałatek T, Trzcinka-Ochocka M, Matczak W, Krajewska B. Studies on the relationship between occupational exposure to manganese and serum Clara cell protein levels in shipyard workers. Trace Elem Electrolytes 2000;17:48-53.
17. Hałatek T, Opalska B, Świercz R, Pałczyński C, Górski P, Rydzyński K, et al. Glutaraldehyde inhalation exposure of rats: Effects on morphology of the lungs and Clara cell protein and hyaluronic acid levels in BAL. Inhal Toxicol 2003;15:85-97.
18. Hałatek T, Opalska B, Wegrowski Y. Clara cell protein and metalloproteinase level in BALF after alumina dust-induced lung injury. In: Marone G, editor. JGC Edition. Naples, Italy: Clinical Immunology and Allergy in Medicine; 2003. p. 307-11.
19. Hałatek T, Wrońska-Nofer T, Gruchała J, Trzcinka-Ochocka M, Stetkiewicz J, Rydzyński K. Pneumotoxic effects of welding fumes: cross-week evaluation of Clara cell protein and manganese in blood of shipyard workers. Trace Elem Electrolytes 2004;21:16-22.
20. 2- microglobulin as early markers of occupational exposure to nitric oxides. Inhal Toxicol 2005;17:87-95.
21. Hałatek T, Opalska B, Rydzyński K, Bernard A. Pulmonary response to methylocyclopentadienyl manganese tricarbonyl treatment in rats: injury and repair evaluation. Histol Histopathol [in press].
22. Marimoto Y, Tanaka I. In vivo studies of man-made mineral fibers-fibrosis-related factors. Ind Health 2001;39:106-13.
23. Pilette C, Godding V, Kiss R, Delos M, Verbeken E, Decaestecker C, et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:185-94.
24. Ekberg-Jansson A, Andersson B, Bake B, Boijsen M, Enanden I, Rosengren A, et al. Neutrophil-associated activation markers in healthy smokers relate to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med 2001;95:363-73.
25. Ye Q, Fujita M, Ouchi H, Inoshima I, Maeyama T, Kuwano K, et al. Serum CC-10 in inflammatory lung diseases. Respiration. 2004;71:505-10.
26. Reader JR, Tepper JS, Schelegle ES, Aldrich MC, Putney LF, Pfeiffer JW, et al. Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol 2003;162:2069-78.
27. Hayashi T, Ishii A, Nakai S, Hasegawa K. Ultrastructure of goblet-cell metaplasia from Clara cell in the allergic asthmatic airway inflammation in a mouse model of asthma in vivo. Virchows Arch 2004;444:66-73.
28. White LR, Steinegger AF, Schlatter C. Pulmonary response following intratracheal instillation of potroom dust from an aluminum reduction plant into rat lung. Environ Res 1987;42:534-45.
29. Tornling G, Blaschke E, Eklund A. Long term effects of alumina on components of bronchoalveolar lavage fluid from rats. Br J Ind Med 1993;50:172-5.
30. Hallgren R, Samuelsson T, Laurent TC, Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis 1989;139:682-7.
31. Cantor JO, Shteyngart B, Cerreta JM, Liu M, Armand G, Turin GM. The effect of hyaluronan on elastic fiber injury in vitro and elastase-induced airspace enlargement in vivo. Proc Soc Exp Biol Med 2000;225:5-71.
32. Rydzyński K, Hałatek T, Stȩpnik M, Tarkowski M. Respiratory allergy and inflamation due to ambient partculate - a European-wide assessment (RAIAP) - Polish experience. Int Rev Allergol Clin Immunol 2002;8:161-6.
33. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sybille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur Resp J 1992;5:1231-8.
34. Habig W, Pabst M, Jacoby W. Glutathione S-transferase: the first step in mercapturic acid formation. J Biol Chem 1970;249:7130-9.
35. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994;218:325-29.
36. Bakowska J, Adamson I. Collagenase and gelatinase activities in bronchoalveolar lavage fluids during bleomycin-induced lung injury. J Pathol 1998;185:319-23.
37. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5.
38. Lemjabbar H, Gosset P, Lambin C, Tillie I, Hartman D, Wallaert B, et al. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999;159:1298-307.
39. Kumagai K, Ohno I, Imai K, Nawata J, Hayashi K, Okada S, et al. The involvement of matrix metalloproteinases in basement membrane injury in a murine model of acute allergic airway inflammation. Clin Exp Allergy 2002;32:1527-34.
40. Yatera K, Morimoto Y, Kim HN, Yamato H, Tanaka I, Kido M. Increased expression of matrix metalloproteinase in Clara cell-ablated mice inhaling crystalline silica. Environ Health Perspect 2001;109:795-9.
41. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998;78:687-98.
42. Cowan MJ, Huang X, Yao XL, Shelhamer JH. Tumor necrosis factor alpha stimulation of human Clara cell secretory protein production by human airway epithelial cells. Ann N Y Acad Sci 2000;923:193-201.
43. Kobayashi H, Terao T. Hyaluronic acid-specific regulation of cytokines by human uterine fibroblasts. Am J Physiol 1997;273:C1151-9.
44. Wallaert B, Colombel JF, Adenis A, Marchandise X, Hallgren R, Janin A, et al. Increased intestinal permeability in active pulmonary sarcoidosis. Am Rev Respir Dis 1992;145:1440-5.
45. Oberson D, Desfontaines L, Pezerat H, Hornebeck W, Sebastien P, Lafuma C. Inhibition of human leukocyte elastase by mineral dust particles. Am J Physiol 1996;270:L761-71.
46. Dai J, Gilks B, Price K, Churg A. Mineral dusts directly induce epithelial and interstitial fibrogenic mediators and matrix components in the airway wall. Am J Respir Crit Care Med 1998;158:1907-13.
47. Fanucchi MV, Buckpitt AR, Murphy ME, Storms DH, Hammock BD, Plopper CG. Development of phase II xenobiotic metabolizing enzymes in differentiating murine Clara cells. Toxicol Appl Pharmacol 2000;168:253-67.
48. Foster JR, Green T, Smith LL, Lewis RW, Hext PM, Wyatt I. Methylene chloride - an inhalation study to investigate pathological and biochemical events occurring in the lungs of mice over an exposure period of 90 days. Fundam Appl Toxicol 1992;18:376-88.
49. Buckpitt A, Chang AM, Weir A, Van Winkle L, Duan X, Philpot R, et al. Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. Mol Pharmacol 1995;47:74-81.
50. Reynolds SD, Giangreco A, Hong KU, McGrath KE, Ortiz LA, Stripp BR. Airway injury in lung disease pathophysiology: selective depletion of airway stem and progenitor cell pools potentiates lung inflammation and alveolar dysfunction. Am J Physiol Lung Cell Mol Physiol 2004;287:L1256-65.
51. Plopper CG, Macklin J, Nishio SJ, Hyde DM, Buckpitt AR. Relationship of cytochrom P-450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar brionchi in mice, hamsters, rats after parenteral administration of naphtalene. Lab Invest 1992;67:553-65.
52. Paige R, Wong V, Plopper C. Dose-related airway-selective epithelial toxicity of 1-nitronaphthalene in rats. Toxicol Appl Pharmacol 1997;147:224-33.